Apixaban May Prevent Stroke Better than Aspirin
If you suffer from a cardiovascular disease, you may be unable to work for an extended period of time. This may lead you to seek long-term disability benefits to help cover lost wages while undergoing treatment.
Aspirin is commonly taken to help prevent strokes and other cardiovascular events. However, apixaban, a new drug developed by Bristol-Myers Squibb and Pfizer, may prevent stroke better than aspirin.
A new study indicates that this experimental drug, apixaban, can help prevent stroke and systemic blood clots in patients who have atrial fibrillation, a disorder of the heart’s rhythm.
Approximately 2.2 million individuals in the United States have been diagnosed with atrial fibrillation. The National Heart, Lung and Blood Institute believe those numbers will double in the next 10 years.
The Food and Drug Administration (FDA) has yet to approve apixaban but if they do, it is anticipated that this new drug will generate more than $10 billion in annual sales.
In a clinical trial, patients who took apixaban only had a 1.6% chance at developing systemic blood clots or having a stroke. In comparison, patients who took aspirin had a 3.6% chance.
If you have been diagnosed with a cardiovascular disease that requires long-term treatment, you should contact a long-term disability associate. They will help you determine if you qualify for long-term disability benefits.
The long-term disability representatives at Disability Help Group have experience with cross examining medical and vocational experts and take time when speaking with you about your case. Call us today at 1-(800)-800-3332 for a FREE consultation.